These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8991624)

  • 1. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
    Patchin GM; Wieland KA; Carmichael JM
    Am J Health Syst Pharm; 1996 Sep; 53(17):2081-2. PubMed ID: 8991624
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
    de Boer WA; Driessen WM; Jansz AR; Tytgat GN
    Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1189-94. PubMed ID: 8789310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
    Claussen DW
    Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
    Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
    Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment strategies for Helicobacter pylori infection.
    Damianos AJ; McGarrity TJ
    Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
    Tkach CL; Ariano RE
    Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
    Piqué JM
    Med Clin (Barc); 2000 Jun; 115(1):23-4. PubMed ID: 10953833
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
    Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 14. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori.
    Seifrit B
    AORN J; 1997 Mar; 65(3):614-6, 619-20. PubMed ID: 9061156
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic resistance of Helicobacter pylori.
    Kusters JG; Kuipers EJ
    Symp Ser Soc Appl Microbiol; 2001; (30):134S-44S. PubMed ID: 11422569
    [No Abstract]   [Full Text] [Related]  

  • 17. Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
    Laine L
    Gastroenterology; 1992 Nov; 103(5):1695-6. PubMed ID: 1426890
    [No Abstract]   [Full Text] [Related]  

  • 18. Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide.
    Drugs R D; 2002; 3(6):402-4. PubMed ID: 12516945
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
    Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of children with Helicobarter pylory by triple therapy can be shortened without the risk of losing it eradicating efficacy. Letter].
    Cilleruelo ML; Urruzuno P; Martínez MJ; Madruga D; Sebastián M; Román E; Barrio A; Manzanares J; Medina E; Sarría J; Sanz JC
    An Esp Pediatr; 1996 Nov; 45(5):550. PubMed ID: 9036795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.